We track breakthroughs in aging and longevity from around the world — giving credit where it's due, without hype, bias, or commercial interest.
📡 Updated monthly. Free for everyone.
One short email per month. No spam. Unsubscribe anytime.
🆕 May 31, 2026 – What is coming up
What's new this month
🕊️ May 2026 — In Progress
Next full archive update: May 31. This month we're tracking emerging organogenesis platforms, new senolytic trials, and AI-discovered biomarkers.
📢 Update — May 4, 2026: The OSK trial has completed enrollment. Safety data expected Q4 2026. Source →
📬 All existing content from April 14 remains. These are additions — nothing removed, nothing repeated.
Browse by topic
🧬 Rejuvenation
Reversing or slowing biological age — epigenetic reprogramming, senolytics, gene therapy, partial reprogramming (global).
💊 Therapeutics
Drugs, supplements, clinical trials — metformin, rapamycin, fisetin, new senolytics, AI‑discovered compounds (global).
🧠 Cognitive Longevity
Brain health, dementia, mental aging — Alzheimer's research, light/sound therapy, nootropics, brain fog (global).
🌍 Exposome & Lifestyle
Environment, diet, exercise, social factors — pollution, sleep, stress, autonomic balance (global).
🤖 AI & Longevity
Artificial intelligence in aging research — AI drug discovery, predictive models, biomarker identification (global).
📊 Biomarkers & Diagnostics
Measuring aging — epigenetic clocks, piRNAs, blood tests, imaging (global).
🩺 Clinical Trials & Regulatory
Human studies, approvals, safety — Phase I/II/III trials, FDA approvals, TAME trial, OSK therapy (global).